LHC Group (NASDAQ:LHCG) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Friday.

LHCG has been the topic of several other research reports. SunTrust Banks reissued a “buy” rating and set a $75.00 target price on shares of LHC Group in a report on Friday, November 3rd. Royal Bank Of Canada boosted their target price on LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Oppenheimer boosted their target price on LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Finally, Bank of America initiated coverage on LHC Group in a report on Monday, August 21st. They set a “buy” rating and a $76.00 target price on the stock. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $77.10.

Shares of LHC Group (NASDAQ:LHCG) opened at $65.43 on Friday. LHC Group has a twelve month low of $41.66 and a twelve month high of $76.14. The company has a market capitalization of $1,190.00, a P/E ratio of 28.33, a P/E/G ratio of 1.96 and a beta of 0.70. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24.

LHC Group (NASDAQ:LHCG) last announced its earnings results on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.04. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The firm had revenue of $272.90 million for the quarter, compared to analysts’ expectations of $265.35 million. During the same quarter in the previous year, the company earned $0.54 earnings per share. The firm’s quarterly revenue was up 18.2% compared to the same quarter last year. analysts expect that LHC Group will post 2.4 EPS for the current year.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction on Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the transaction, the chief operating officer now owns 109,235 shares of the company’s stock, valued at $7,137,414.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 14.80% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Public Employees Retirement System of Ohio raised its stake in LHC Group by 4,288.5% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 56,129 shares of the health services provider’s stock valued at $3,981,000 after purchasing an additional 54,850 shares during the period. Algert Global LLC raised its stake in LHC Group by 32.2% during the 3rd quarter. Algert Global LLC now owns 48,543 shares of the health services provider’s stock valued at $3,443,000 after purchasing an additional 11,836 shares during the period. California Public Employees Retirement System raised its stake in LHC Group by 26.7% during the 3rd quarter. California Public Employees Retirement System now owns 48,272 shares of the health services provider’s stock valued at $3,423,000 after purchasing an additional 10,172 shares during the period. Vident Investment Advisory LLC acquired a new stake in LHC Group during the 3rd quarter valued at $2,448,000. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp acquired a new stake in LHC Group during the 3rd quarter valued at $2,155,000. 85.25% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/12/02/valuengine-downgrades-lhc-group-lhcg-to-hold.html.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.